Discontinued
SALBUTAMOL CIPLA salbutamol 2.5mg/2.5mL (as sulfate) inhalation ampoules
salbutamol sulfate · 3 mg Inhalation, conventional
- Deletion from market
- 24 June 2026
- TGA row last updated
- 20 July 2026
- ARTG ID
- 115652
- Sponsor
- Cipla Australia Pty Ltd
- Sponsor phone
- 0396964413
- Shortage impact
- Low
- Availability
- Unavailable
Reason reported to TGA
Manufacturing
TGA management action
An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
What to do
- 1.This product is discontinued in the TGA export — Ask your prescriber or pharmacist about a product that is still supplied. Do not stop treatment without that advice.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:15:07 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.